Published in Mitochondrion on November 28, 2014
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther (2000) 3.52
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS (1998) 3.16
Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol (2008) 2.95
Mitochondrial disease: a practical approach for primary care physicians. Pediatrics (2007) 2.06
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood (2001) 1.76
A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen (2007) 1.49
Toxicity of antiretroviral therapy and implications for drug development. Nat Rev Drug Discov (2003) 1.42
Serum cytochrome c indicates in vivo apoptosis and can serve as a prognostic marker during cancer therapy. Int J Cancer (2005) 1.17
Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection. Clin Infect Dis (2005) 1.13
Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol (2010) 1.09
Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS. J Int AIDS Soc (2013) 0.97
HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol (2013) 0.91
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C. Transl Res (2007) 0.91
Cytochrome c: a non-invasive biomarker of drug-induced liver injury. J Appl Toxicol (2008) 0.89
Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury. Expert Opin Drug Metab Toxicol (2012) 0.89
Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-γ inhibition. Clin Pharmacol Ther (2014) 0.89
Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor. Antimicrob Agents Chemother (2002) 0.88
Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice. BMC Gastroenterol (2010) 0.85